Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: Half of the episodes of neonatal sepsis are acquired in the community with a high percentage of mortality and complications. Objective: To estimate the direct costs of hospitalizations due to systemic neonatal infection acquired in the community in low-risk newborns. Materials and methods: For the estimation of costs, we used the perspective of the health systems and the microcosting technique and we established the duration of hospitalization as the time horizon. We identified cost-generating events through expert consensus and the quantification was based on the detailed bill of 337 hospitalized newborns diagnosed with neonatal infection. The costs of the medications were calculated based on the drug price information system (SISMED) and the ISS 2001 rate manuals adjusting percentage, and the mandatory insurance rates for traffic accidents (SOAT). We used the bootstrapping method for cost distribution to incorporate data variability in the estimate. Results: We included the medical care invoices for 337 newborns. The average direct cost of care per patient was USD$ 2,773,965 (Standard Deviation, SD=USD$ 198,813.5; 95% CI: $ 2,384,298 - $ 3,163,632). The main cost-generating categories were hospitalization in intensive care units and health technologies. The costs followed a log-normal distribution. Conclusions: The categories generating the greatest impact on the care costs of newborns with infection were hospitalization in neonatal units and health technologies. The costs followed a log-normal distribution.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055585PMC
http://dx.doi.org/10.7705/biomedica.5196DOI Listing

Publication Analysis

Top Keywords

neonatal infection
12
acquired community
12
direct costs
8
infection acquired
8
units health
8
health technologies
8
technologies costs
8
costs log-normal
8
log-normal distribution
8
costs
6

Similar Publications

To analyze in-hospital mortality in children undergoing congenital heart interventions in the only public referral center in Amazonas, North Brazil, between 2014 and 2022. This retrospective cohort study included 1041 patients undergoing cardiac interventions for congenital heart disease, of whom 135 died during hospitalization. Records were reviewed to obtain demographic, clinical, and surgical data.

View Article and Find Full Text PDF

A woman, gravida 5, para 3, presented with fetal ascites at 19 weeks of gestation. Urinary ascites was initially suspected because of massive ascites and oligohydramnios; however, biochemical analysis of fetal ascites was inconsistent with this diagnosis. A peritoneal-amniotic shunt was placed to prevent pulmonary hypoplasia.

View Article and Find Full Text PDF

Background: The neonatal period is critical for oral microbiome establishment, but temporal patterns in preterm newborns remain unclear. This study examined longitudinal microbiome changes in full-term and preterm newborns and assessed perinatal and clinical influences.

Methods: Oral swabs were collected from 98 newborns (23 full-term, 75 preterm).

View Article and Find Full Text PDF

Using molecular methods to diagnose, classify, and treat neonatal sepsis: a scoping review.

Front Pediatr

August 2025

Department of Neonatal Research, Inova Health Services, Falls Church, VA, United States.

Introduction: Neonatal sepsis is a dysregulated immune response to bloodstream infection causing serious disease and death. Our review seeks to integrate the knowledge gained from studies of multiple molecular methods- such as genomics, metabolomics, transcriptomics, and the gut microbiome- in the setting of neonatal sepsis that may improve the diagnosis, classification, and treatment of the disease. Sepsis claims over 200,000 lives annually worldwide and remains a top 10 cause of infant mortality in the US.

View Article and Find Full Text PDF

Healthcare-associated infections (HAIs) continue to pose major risks to pediatric and neonatal patients, whose immature immune systems and unique vulnerabilities demand tailored infection prevention strategies. Traditional methods, including chemical disinfectants, procedural protocols, and physical hygiene measures, have contributed to reductions in HAIs but remain limited by human error, environmental toxicity, and the rise of antimicrobial resistance. Advances in disinfection technologies, particularly ultraviolet-C (UV-C) systems, offer promising new avenues for safer, more effective pathogen control.

View Article and Find Full Text PDF